Medical device makers Symetis Inc. and Endoluminal Sciences are reaching across oceans to co-develop a new generation of transcatheter aortic valve implantation systems featuring "active anti-paravalvular leak technology."
The duo entered into a license agreement to incorporate Endoluminal Sciences’ anti-leak system into Symetis’ Acurate TA and Acurate TF product lines, according to a press release.